Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat

British Journal of Pharmacology

Volumn 121, Issue 8, 1997, Pages 1758-1762

  Jackson, Helen C ^a   Needham, Andrew M ^a   Hutchins, Lisa J ^a   Mazurkiewicz, Sarah E ^a   Heal, David J ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

5 hydroxytryptamine; Food intake; Monoamine reuptake inhibition; Noradrenaline; Serotonin noradrenaline reuptake inhibitor (SNRI); Sibutramine

Indexed keywords

DULOXETINE; FENFLURAMINE; FLUOXETINE; NISOXETINE; NORADRENALIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DARKNESS; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FOOD INTAKE; MALE; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; CYCLOBUTANES; CYCLOHEXANOLS; EATING; FENFLURAMINE; FLUOXETINE; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; OBESITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030860731     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701312     Document Type: Article

References (48)

1. BOLDEN-WATSON, C. & RICHELSON, E. (1993). Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci., 52, 1023-1029.
2. BUCKETT, W.R., THOMAS, P.C. & LUSCOMBE, G.P. (1988). The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog. Neuro-Psychopharmacol. Biol. Psychiat., 12, 575-584.
3. 3H]5-HT uptake: Effect of administration of various antidepressant treatments. Neuropharmacology, 32, 737-743.
4. CONNOLEY, I.P., FROST, I., HEAL, D.J. & STOCK, M.J. (1996). Role of β-adrenoceptors in mediating the thermogenic effects of sibutramine. Br. J. Pharmacol., 117, 170P.
5. CONNOLEY, I.P., HEAL, D.J. & STOCK, M.J. (1995). A study in rats of the effects of sibutramine on food intake and thermogenesis. Br. J. Pharmacol., 114, 388P.
6. CURZON, G., GIBSON, E.L. & OLUYOMI, A.O. (1997). Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol. Sci., 18, 21-25.
7. DAVIS, R. & FAULDS, D. (1996). Dexfenfluramine: An updated review of its therapeutic use in the management of obesity. Drugs, 52, 696-724.
8. DUMONT, C., LAURENT, J., GRANDADAM, A. & BOISSIER, J.R. (1981). Anorectic properties of a new long acting serotonin uptake inhibitor. Life Sci., 28, 1939-1945.
9. FANTINO, M. & SOUQUET, A.-M. (1995). Effects of Metabolites 1 and 2 of sibutramine on the short-term control of food intake in the rat. Int. J. Obesity, 19, 145.
10. FERGUSON, J.M & FEIGHNER, J.P. (1987). Fluoxetine-induced weight loss in overweight non-depressed humans. Int. J. Obesity, 11, 163-170.
11. FERNÁNDEZ-SOTO, M.L., GONZÁLEZ-JIMÉNEZ, A., BARREDOACEDO, F., LUNA DEL CASTILLO, J.D. & ESCOBAR-JIMÉNEZ, F (1995). Comparison of fluoxetine and placebo in the treatment of obesity. Ann. Nutr. Metab., 39, 159-163.
12. FOGELSON, D.L. (1991). Weight gain during fluoxetine treatment. J. Clin. Psychopharmacol., 11, 220-221.
13. FULLER, R.W., SNODDY, H.D. & MOLLOY, B.B. (1975). Blockade of amine depletion by nisoxetine in comparison to uptake inhibitors. Psychopharmacol. Commun., 1, 455-464.
14. FULLER, R.W., SNODDY, H.D. & ROBERTSON, D.W (1988). Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: Uptake inhibition versus release. Pharmacol. Biochem. Behav., 30, 715-721.
15. GARATTINI, S., BIZZI, A., CODEGONI, A.M., CACCIA, S. & MENNINI, T. (1992). Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Am. J. Clin. Nutr., 55, 160S-166S.
16. GARATTINI, S., MENNINI, T. & SAMANIN, R. (1989). Reduction of food intake by manipulation of central serotonin: Current experimental results. Br. J. Psychiat., 155, 41-51.
17. GOLDSTEIN, D.J., RAMPEY, A.H., ENAS, G.G., POTVIN, J.H., FLUDZINSKI, L.A. & LEVINE, L.R. (1994). Fluoxetine: A randomised clinical trial in the treatment of obesity. Int. J. Obesity, 18, 129-135.
18. GOUDIE, A.J., THORNTON, E.W. & WHEELER, T.J. (1976). Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotonergic inhibition of feeding. J. Pharm. Pharmacol., 28, 318-320.
19. GUALTIERI, C.T. (1991). Paradoxical effects of fluoxetine. J. Clin. Psychopharmacol., 11, 393-394.
20. GUNDLAH, C., MARTIN, K.F., HEAL, D.J., SCHJOTT, J. & AUERBACH, S.B. (1996). In vivo criteria to differentiate monoamine uptake inhibitors (MARIs) from serotonin releasing drugs: sibutramine is a MARI. Soc. Neurosci. Abs., 22, 612.
21. HALFORD, J.C.G. & BLUNDELL, J.E. (1996). Metergoline antagonises fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence. Pharmacol. Biochem. Behav., 54, 745-751.
22. HALFORD, J.C.G., HEAL, D.J. & BLUNDELL, J.E. (1995). Effects in the rat of sibutramine on food intake and the behavioural satiety sequence. Br. J. Pharmacol., 114, 387P.
23. HOLLIDAY, S.M. & BENFIELD, P. (1995). Venlafaxine: A review of its pharmacology and therapeutical potential in depression. Drugs, 49, 280-294.
24. JACKSON, H.C., BEARHAM, M.C., MAZURKIEWICZ, S.E., HEAL, D.J. & BUCKETT, W.R. (1996a). Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and NA reuptake inhibitor sibutramine in the rat. Br. J. Pharmacol., 117, 168P.
25. 3 receptor subtypes. Br. J. Pharmacol., 114, 391P.
26. JACKSON, H.C., HUTCHINS, L.J., MAZURKIEWICZ, S.E., HEAL, D.J. & BUCKETT, W.R. (1996b). Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br. J. Pharmacol. 117, 323P.
27. KASAMO, K., BLIER, P. & DE MONTIGNY, C. (1996). Blockade of the serotonin and norepinephrine uptake processes by duloxetine: In vitro and in vivo studies in the rat brain. J. Pharmacol. Exp. Ther., 277, 278-286.
28. KATOH, A., EIGYO, M., ISHIBASHI, C., NAITOH, Y., TAKEUCHI, M., IBII, N., IKEDA, M. & MATSUSHITA, A. (1995). Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats. J. Pharmacol. Exp. Ther., 272, 1067-1075.
29. LANE, R.M. (1996). Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors. Int. Clin. Psychopharmacol., 11, 31-61.
30. LAWTON, C.L., WALES, J.K., HILL, A.J. & BLUNDELL, J.E. (1995). Serotoninergic manipulation, meal-induced satiety and eating pattern: effect of fluoxetine in obese female subjects. Obesity Res., 3, 345-356.
31. LEVINE, L.R., ROSENBLATT, S. & BOSOMWORTH, J. (1987). Use of a serotonin reuptake inhibitor, fluoxetine, in the treatment of obesity. Int. J. Obesity, 11, 185-190.
32. LIGHTOWLER, S., WOOD, M., BROWN, T., GLEN, A., BLACKBURN, T., TULLOCH, I. & KENNETT, G. (1996). An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats. Eur. J. Pharmacol., 296, 137-143.
33. LUSCOMBE, G.P., HOPCROFT, R.H., THOMAS, P.C. & BUCKETT, W.R. (1989). The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology, 28, 129-134.
34. MENNINI, T., BORRONI, E., SAMANIN, R. & GARATINNI, S. (1981). Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin. Neurochem. Int., 3, 289-294.
35. MENNINI, T., GARATTINI, S. & CACCIA, S. (1985). Anorectic effect of fenfluramine isomers and metabolites: Relationship between brain levels and in vitro potencies on serotonergic mechanisms. Psychopharmacology, 85, 111-114.
36. PAUL, I.A., DUNCAN, G.E., KUHN, C., MUELLER, R.A., HONG, J.-S. & BREESE, G.R. (1990). Neural adaptation in imipramine-treated rats processed in forced swim test: Assessment of time course, handling, rat strain and amine uptake. J. Pharmacol. Exp. Ther., 252, 997-1005.
37. PIJL, H., KOPPESCHAAR, H.P., WILLEKENS, F.L., OP DE KAMP, I., VELDHUIS, H.D. & MEINDERS, A.E. (1991). Effect of serotonin re-uptake inhibition by fluoxetine on food intake and spontaneous food choice in obesity. Int. J. Obesity, 15, 237-242.
38. PROW, M.R., HANNON, S.D., ASPLEY, S., MARTIN, K.F. & HEAL, D.J. (1996). Comparison of the effects of sibutramine, fluoxetine and d-fenfluramine on extracellular 5-HT in rat anterior hypothalamus: An in vivo microdialysis study. Br. J. Pharmacol., 120, 351P.
39. ROWLAND, N.B., MORIEN, A. & LI, B.-H. (1996). The physiology and brain mechanisms of feeding. Nutrition, 12, 626-639.
40. RYAN, D.H., KAISER, P. & BRAY, G.A. (1995). Sibutramine: A novel new agent for obesity treatment. Obesity Res., 3, 553S-559S.
41. STRICKER-KRONGRAD, A., SOUQUET, A.-M. & BURLET, C. (1995). Effects of sibutramine on feeding behaviour in obese and lean Zucker rats. Int. J. Obesity, 19, 145.
42. WEINTRAUB, M., RUBIO, A., GOLIK, A., BYRNE, L. & SCHEINBAUM, M.L. (1991). Sibutramine in weight control: A dose-ranging, efficacy study. Clin. Pharmacol. Ther., 50, 330-337.
43. WISE, S.D. (1992). Clinical studies with fluoxetine in obesity. Am. J. Clin. Nutr., 55, 181S-184S.
44. WONG, D.T. & BYMASTER, F.P. (1976). Effect of nisoxetine on uptake of catecholamines in synaptosomes isolated from discrete regions of rat brain. Biochem. Pharmacol., 25, 1979-1983.
45. WONG, D.T., BYMASTER, F.P. & ENGLEMAN, E.A. (1995). Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci., 57, 411-441.
46. WONG, D.T., BYMASTER, F.P., MAYLE, D.A., REID, L.R., KRUSHINSKI, J.H. & ROBERTSON, D.W. (1993). LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology, 8, 23-33.
47. WONG, D.T., REID, L.R. & THRELKELD, P.G. (1988). Suppression of food intake in rats by fluoxetine: Comparison of enantiomers and effects of serotonin antagonists. Pharmacol. Biochem. Behav., 31, 475-479.
48. YARDLEY, J.P., HUSBANDS, G.E.M., STACK, G., BUTCH, J., BICKSLER, J., MOYER, J.A., MUTH, E.A., ANDREE, T., FLETCHER III, H., JAMES, M.N.G. & SIELECKI, A.R. (1990). 2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: Synthesis and antidepressant activity. J. Med. Chem., 33, 2899-2905.